🇺🇸 FDA
Patent

US 11807882

Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

granted A61KA61K31/397A61K38/00

Quick answer

US patent 11807882 (Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
56
CPC classes
A61K, A61K31/397, A61K38/00, A61K45/06